We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
High-dose BEAM chemotherapy with autologous peripheral blood progenitor-cell transplantation for unselected patients with primary refractory or relapsed Hodgkin's disease.
- Authors
Argiris, A; Seropian, S; Cooper, D L
- Abstract
The use of autologous peripheral blood progenitor cells (PBPC) expedites hematologic recovery and reduces the costs of transplantation in comparison with autologous bone marrow; however, its efficacy in patients with Hodgkin's disease has been questioned. We evaluated the results of autologous PBPC transplantation in a population of unselected and uniformly treated patients with primary refractory or relapsed Hodgkin's disease.
- Publication
Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Vol 11, Issue 6, p665
- ISSN
0923-7534
- Publication type
Journal Article
- DOI
10.1023/a:1008396525292